Financial Data and Key Metrics Changes - The company ended 2025 with cash totaling $7.6 million, an increase from $3.7 million as of December 31, 2024 [12] - The net loss for Q4 2025 was $1.6 million, or $0.73 per diluted share, compared to a net loss of $2.8 million, or $3.29 per diluted share for Q4 2024 [16] - For the full year 2025, the net loss was $8 million, or $5.32 per diluted share, down from a net loss of $14.1 million, or $17.45 per share in 2024 [16] Business Line Data and Key Metrics Changes - Research and development expenses for Q4 2025 were $0.3 million, down from $0.8 million in Q4 2024, primarily due to decreased manufacturing and consulting costs [13] - For the full year 2025, R&D expenses totaled $1.8 million, a significant decrease from $5.4 million in 2024, attributed to lower manufacturing and consulting costs [14] - General and administrative expenses for Q4 2025 were $1.3 million, down from $2 million in Q4 2024, mainly due to reduced compensation-related costs and professional fees [14] Market Data and Key Metrics Changes - The company presented at IDWeek in Atlanta, highlighting the potential of ibezapolstat and its microbiome-sparing properties, which could position it favorably in the market [4][5] - The FDA's recent announcement regarding a one-trial requirement for registration could significantly impact the company's clinical development programs and market entry strategy [10] Company Strategy and Development Direction - The company is launching a new clinical trial program for ibezapolstat in patients with recurrent CDI, aiming to shift treatment paradigms from two agents to one [7][19] - The company is pursuing funding opportunities for its phase 3 clinical trial programs and exploring alternative financial pathways [11] - The focus on U.S.-based manufacturing aligns with government interests in public-private partnerships, potentially enhancing funding opportunities [41] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the macroeconomic challenges and emphasized the competitive profile of ibezapolstat [12] - The potential for ibezapolstat to be the first agent to demonstrate clinical success in both treating and preventing recurrent CDI was highlighted as a significant opportunity [19] - The company is optimistic about the implications of the FDA's new guidance on clinical trial requirements for its development programs [10] Other Important Information - The company received a new patent for its Pol IIIC inhibitors, extending protection to December 2039 [10] - The clinical program for ibezapolstat has received fast track designations from the FDA, enhancing its development prospects [11] Q&A Session Summary Question: What is the primary endpoint for the recurrent CDI trial and its cost? - The primary endpoint is prevention of recurrence, with an evaluation period of eight weeks and a trial cost estimated between $4 million and $5 million [22][32] Question: When will the pilot study start and conclude? - Enrollment for the pilot study is expected to begin in the second half of 2026, with full enrollment anticipated to take 12-15 months [33] Question: How many patients will be needed for the phase 3 trial? - The current projection for the phase 3 trial in recurrent CDI is between 360 and 400 patients, depending on data from the open-label trial [37] Question: Is U.S.-based manufacturing a focus for the company? - Yes, the company is engaging with government agencies regarding U.S.-based manufacturing, which is seen as beneficial for securing funding [41]

Financial Data and Key Metrics Changes - Fiscal 2026 first quarter revenue totaled $278.6 million, down 17% from the prior year, driven by a 30% decrease in pricing due to higher industry supply [17] - Despite lower revenue, gross profit remained consistent at $31.6 million, leading to a gross margin increase of 190 basis points to 11.3% compared to the same period last year [17][18] - Adjusted EBITDA increased 5% to $18.5 million compared to $17.7 million last year, driven by higher avocado volume sold and improved per unit margins [21] Business Line Data and Key Metrics Changes - Marketing and Distribution segment net sales decreased 21% to $234.8 million, but adjusted EBITDA increased 33% to $12.9 million, reflecting higher avocado volume sold and solid per unit margins [21] - International Farming segment total sales increased 15% to $10.6 million, with adjusted EBITDA rising 28% to $2.3 million due to improved pack house utilization [22] - Blueberry segment total sales increased 12% to $40.8 million, but adjusted EBITDA decreased to $3.3 million due to lower per acre yields [23] Market Data and Key Metrics Changes - Mexican supply was abundant this quarter, with higher yields in the current harvest season compared to last year, contributing to a 14% growth in avocado volumes [6][17] - Household penetration of avocados reached approximately 72%, with per capita consumption nearly tripling over the past two decades, indicating strong demand trends [8] Company Strategy and Development Direction - The company is focused on leveraging the Calavo acquisition to enhance its core avocado business and expand into prepared foods, which is seen as a strategic opportunity [10][12] - Integration planning for the Calavo acquisition is underway, with expectations of achieving at least $25 million in annualized cost synergies within 18 months of closing [14] - The company aims to balance reinvestment in the business with returning capital to shareholders as free cash flow ramps up [15][49] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying strength of the business model despite near-term pricing pressures, emphasizing the long-term growth potential in avocado consumption [28] - The company anticipates a lower pricing environment in the second quarter, with expected avocado industry volumes increasing by approximately 10%-15% [25][26] - Management highlighted the importance of maximizing productivity and strengthening customer partnerships to drive long-term value creation [28] Other Important Information - SG&A expenses increased by $6.9 million, or 31%, primarily due to transaction advisory costs associated with the Calavo acquisition [18] - Cash and cash equivalents were $44.8 million as of January 31, 2026, down from $64.8 million as of October 31, 2025 [24] Q&A Session Summary Question: Insights on Calavo acquisition and synergy realization - Management feels confident about the $25 million synergy estimate and sees opportunities for further upside, focusing on cost-related synergies and growth potential [31][33] Question: Impact of pricing environment on margins - Management acknowledged that while lower prices compress margins, the focus remains on maintaining profitability through volume and per unit margins [39][41] Question: Timeline for blueberry farms reaching full productivity - Management expects blueberry farms to reach full productivity within 12-18 months, with improved yields anticipated as the plants mature [45][47] Question: Long-term capital allocation strategy - Management is committed to balancing debt management, reinvestment in growth, and returning capital to shareholders, with discussions ongoing about shareholder returns [49][51]

Financial Data and Key Metrics Changes - Total revenue for 2025 increased by 16% year-over-year to $469.5 million, with net income improving to $41.9 million and adjusted EBITDA increasing approximately threefold to $56 million [4][5] - Operating cash flow rose by 23% to $81.1 million, driven by improving power market conditions [4] - For Q4 2025, electric sales increased by 3% to $71.6 million, while coal sales rose by 24% to $29.1 million [13][14] - Total operating revenue for Q4 increased by 8% to $102.4 million, with a net loss of $0.2 million compared to a net loss of $215.8 million in the prior year [14][15] Business Line Data and Key Metrics Changes - Electric sales were the primary driver of revenue growth, increasing approximately 19% to $310.7 million for the full year [4] - Coal sales increased by 8% year-over-year to $148.7 million, supported by both internal fuel needs and third-party customers [5] - In Q4, coal sales growth was driven by higher third-party shipments, reflecting production optimization at Sunrise Coal [14] Market Data and Key Metrics Changes - The MISO region is experiencing strong demand for reliable dispatchable generation, tightening supply conditions and increasing the value of accredited capacity [6][7] - The company has made progress in selling energy and capacity at elevated prices, with competitive offers for accredited capacity over a decade in length [7] Company Strategy and Development Direction - The company is advancing its transformation into a vertically integrated independent power producer, focusing on maintaining operational reliability and executing strategic initiatives for long-term growth [4][9] - Plans to add up to 515 MW of natural gas generation under the ERAS program, targeting completion around Q3 2029, leveraging existing infrastructure at the Merom site [8][9] - The company aims to maintain a disciplined approach to capital allocation, with capital expenditures expected to increase modestly in 2026 compared to 2025 [9][17] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the current market conditions, noting increased interest and pricing pressure for long-term power purchase agreements (PPAs) [22][23] - Operational challenges at the Merom power plant were acknowledged, with planned maintenance expected to improve performance ahead of peak summer demand [5][26] - The company is actively negotiating with multiple counterparties for equipment and PPAs to support the gas expansion project [31][32] Other Important Information - The company completed a $25 million prepaid energy forward sales contract and raised approximately $14 million through an ATM offering [17] - A new $120 million senior secured credit facility was established to support general corporate purposes and potential equipment deposits for the gas generation expansion [18] Q&A Session Summary Question: What are the main gating items for long-term PPA opportunities? - Management indicated that multiple parties are involved in negotiations, with increasing interest and pricing pressure in the market [22][23] Question: Can you provide details on the operational issues at Merom? - Management noted equipment failures affecting performance, with a planned major maintenance outage expected to improve reliability [25][26] Question: What factors will determine the completion date for the natural gas expansion? - Key factors include securing equipment in a timely manner and aligning long-term PPAs to support the project [31][32] Question: How will recent EPA decisions impact the business? - Most plants, including Merom, are already MACT compliant, and while ongoing costs exist, the changes may ease operational burdens [34] Question: Will long-term PPAs be announced in several tranches? - Management expects to announce multiple tranches rather than a single large deal [37] Question: What is the outlook for capital expenditures in 2026? - Capital expenditures are expected to be modestly higher than 2025 levels, excluding ERAS developments [44]

Financial Data and Key Metrics Changes - The company reported approximately $690,000 in revenue from continuing operations for fiscal year 2025, entirely generated from the TrueCut Motion platform and related motion grading services [28] - The cash balance at the end of 2025 was approximately $11.2 million, and following the sale of the Shanghai subsidiary, the cash balance was projected to be approximately $58 million by March 31, 2026 [30][33] - Operating expenses are expected to be approximately $2 million per quarter starting in the second quarter of 2026 [37] Business Line Data and Key Metrics Changes - The sale of the Shanghai semiconductor subsidiary allowed the company to reposition itself as a global technology licensing business focused on cinematic visualization solutions [11] - The company has transformed into a lean, asset-light organization with less than 25 full-time employees, with about 60% dedicated to R&D [14] Market Data and Key Metrics Changes - The company is focusing on expanding its TrueCut Motion platform, which is being utilized by leading filmmakers for premium theatrical releases [15][17] - There is a growing number of premium large format (PLF) screens, with major exhibitors allocating a majority of their new capital expenditures to enhance premium theatrical experiences [18] Company Strategy and Development Direction - The immediate strategic focus is on enabling additional premium large format theatrical experiences and building a profitable licensing business centered around cinematic and visual enhancement solutions [25] - The company aims to engage with studios and distributors to deliver premium experiences to home entertainment devices, which is expected to be a significant revenue source [45] Management's Comments on Operating Environment and Future Outlook - Management believes there is a large and compelling market opportunity for their motion grading technology and expertise, especially with the increasing demand for premium content [22] - The company is committed to maintaining a robust balance sheet and efficiently using cash to build its licensing business [25] Other Important Information - The company has approximately $1.2 million in escrow related to a tax dispute that is expected to be resolved in its favor [9][32] - The company has no intention of selling more patents and is actively trying to add to its patent portfolio specific to its go-forward business [58] Q&A Session Summary Question: What are the best near-term opportunities for revenue? - The company is focused on creating cinematic high frame rate content under the TrueCut Motion brand and expects to engage with studios and distributors for home entertainment [40][41] Question: What is the margin structure as revenue forms? - The company expects very high margins on revenue from content creation, distribution licensing, and device certification licensing [47] Question: What are the top priorities for 2026? - The top priorities include licensing the TrueCut Motion technology to third parties and developing the demand profile for the technology [59]

Financial Data and Key Metrics Changes - Consolidated operating income was approximately $800 thousand in Q4 2025, down from $1.5 million in Q4 2024, impacted by $400 thousand in M&A-related expenses [7] - Revenue increased to $11.9 million in Q4 2025 from $10.8 million in Q4 2024 [10] - Adjusted EBITDA decreased to $1.1 million in Q4 2025 from $2.1 million in the prior year [10] - Net income was approximately $300 thousand or $0.01 per diluted share in Q4 2025, compared to a loss of approximately $200 thousand or $0.01 per diluted share in Q4 2024 [10] Business Line Data and Key Metrics Changes - The industrial assets division reported operating income of approximately $1.1 million in Q4 2025, up from approximately $800 thousand in the prior year [7] - The financial assets division reported operating income of approximately $900 thousand in Q4 2025, down from $1.9 million in the prior year [7] - ALT, a part of the industrial assets division, reported operating income of $538 thousand in Q4 2025, compared to $276 thousand in the prior year [8] Market Data and Key Metrics Changes - Consumer loan delinquencies remain elevated, particularly in credit card and auto loans, which are expected to lead to increased charge-offs moving forward [9] - The company anticipates a significant amount of loans in the commercial real estate (CRE) market will be released due to ongoing pressures [5][21] Company Strategy and Development Direction - The company aims to define 2026 as the "year of the needle mover," focusing on larger transactions and aggressive M&A activities [5] - The recent acquisition of DebtX is expected to enhance capabilities in the financial asset segment and is projected to be accretive in 2026 [10][18] - The company has moved into a new facility designed to accelerate growth and increase operational efficiency [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about 2026, indicating a shift from a cautious approach to more aggressive transaction activity as companies are expected to release assets [3][4] - There is a belief that the current economic environment will lead to increased activity in auctions and larger transactions as companies move past a "wait and see" mentality [27] Other Important Information - The company has a strong balance sheet with stockholders' equity of $67 million as of December 31, 2025, and a cash balance of $20.5 million [11] - The company plans to resume share repurchases after authorizing a new program for up to $7.5 million [12] Q&A Session Summary Question: Clarification on DebtX acquisition accretion - The company expects the DebtX acquisition to be accretive on both operating income and net income basis [18] Question: Seasonality of DebtX business - DebtX typically has a strong Q4, with over 50% of their revenue often generated in that quarter [19] Question: Exposure to private credit market - The DebtX acquisition provides exposure to the private credit market, particularly in relation to loans struggling to be refinanced [21] Question: Larger transactions in 2026 - Management noted a general hesitation in 2025 due to geopolitical and macroeconomic factors, but signs indicate a return to larger transactions in 2026 [26][27] Question: Specialty lending performance - The modestly negative performance in specialty lending was attributed to a lack of funding and the need to increase loan amounts in 2026 [32]

Financial Data and Key Metrics Changes - Abacus Global Management reported total revenue growth of 116% in Q4 2025, reaching $71.9 million compared to $33.2 million in the prior year [31] - For the full year 2025, revenue increased by 110% to $235.2 million from $111.9 million in the previous year [31] - Adjusted net income for Q4 2025 grew 71% to $23 million, up from $13.4 million in the prior year [32] - Adjusted EBITDA for Q4 2025 increased by 132% to $38.6 million, with an adjusted EBITDA margin of 54% [33] - Full year adjusted EBITDA rose 115% to $132.6 million, maintaining a margin of 56% [34] - The company initiated its full year 2026 outlook for adjusted net income between $96 million and $104 million, implying up to 22% growth compared to 2025 [36] Business Line Data and Key Metrics Changes - The Life Solutions segment continues to drive revenue growth, with significant contributions to overall performance [31] - In Q4 2025, capital deployed increased by 82% to $230.7 million, compared to $126.5 million in the prior year [30] - The asset management segment generated nearly $34 million in management fees in 2025, with over $3 billion in fee-paying AUM [11][28] Market Data and Key Metrics Changes - The company noted a robust demand for longevity-linked and asset-backed strategies, driven by institutional allocators seeking uncorrelated return streams [21] - Abacus paid nearly a quarter of a billion dollars to policyholders in 2025, highlighting the liquidity provided to policyholders during market uncertainty [8] Company Strategy and Development Direction - Abacus aims to grow its fee-paying AUM to over $5 billion by the end of 2026, with a long-term target of $50 billion by 2030 [28] - The company is focused on building a recurring revenue model, targeting 70% of total revenue from recurring sources over the next five years [29] - The recent acquisition of a minority position in Manning & Napier is expected to create synergies across wealth management and life insurance [14][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business model and execution, citing 11 consecutive quarters of outperformance [5][38] - The current market environment is seen as favorable for Abacus, with a focus on educating the investment community about the company's value proposition [39] - The company is committed to maximizing long-term shareholder value through disciplined capital allocation and strategic growth initiatives [17][18] Other Important Information - The company has a strong balance sheet with cash and cash equivalents of $38.1 million and outstanding long-term debt of $405.8 million as of December 31, 2025 [36] - Abacus is leveraging proprietary mortality data to enhance its underwriting and asset management capabilities, positioning itself as a valuable data provider in the industry [7][12] Q&A Session Summary Question: Can you expand on how the investor demand side has evolved since the last quarter? - Management noted that demand has continued to increase, particularly in light of recent market volatility, which has created more opportunities for securitization [44][45] Question: Is it fair to assume the next securitization could be larger than the first one? - Management confirmed that the goal is to target a larger securitization, potentially exceeding $100 million based on current demand [46][48] Question: What is the pipeline like for potential acquisitions? - Management indicated that there are ongoing discussions for strategic acquisitions that would create synergies, emphasizing a patient and diligent approach [77]

Financial Data and Key Metrics Changes - Fiscal 2026 first quarter revenue totaled $278.6 million, down 17% from the prior year, driven by a 30% decrease in pricing due to higher industry supply [17] - Despite lower revenue, gross profit remained consistent at $31.6 million, leading to a gross margin increase of 190 basis points to 11.3% compared to the same period last year [17][18] - Adjusted EBITDA increased 5% to $18.5 million compared to $17.7 million last year, driven by higher avocado volume sold and improved per-unit margins [21] Business Line Data and Key Metrics Changes - Marketing and Distribution segment net sales decreased 21% to $234.8 million, but segment-adjusted EBITDA increased 33% to $12.9 million due to higher avocado volume sold and solid per-unit margins [21] - International Farming segment total sales increased 15% to $10.6 million, with segment-adjusted EBITDA increasing 28% to $2.3 million due to improved pack house utilization [22] - Blueberry segment total sales increased 12% to $40.8 million, but segment-adjusted EBITDA decreased to $3.3 million due to lower per-acre yield impacting profitability [23] Market Data and Key Metrics Changes - Avocado household penetration reached approximately 72%, with per capita consumption nearly tripling over the past two decades, indicating strong demand trends [7][8] - The broader demand environment for avocados continues to trend positively, supported by health and wellness trends and recent USDA dietary guidelines [7][8] Company Strategy and Development Direction - The company is focused on leveraging the Calavo acquisition to enhance its core avocado business and expand into prepared foods, which is seen as a strategic opportunity [10][12] - Integration planning for the Calavo acquisition is underway, with expectations of achieving at least $25 million in annualized cost synergies within 18 months of closing [14] - The company aims to balance reinvestment in the business with returning capital to shareholders as free cash flow ramps up [15][50] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a lower pricing environment while focusing on volume growth and per-unit margins [6][29] - The company anticipates a challenging second quarter due to lower pricing and delayed California harvest, which may impact profitability [25][26] - Despite near-term challenges, management remains optimistic about long-term growth driven by structural tailwinds in avocado consumption [29] Other Important Information - SG&A expenses increased by $6.9 million, or 31%, primarily due to transaction advisory costs related to the Calavo acquisition [18] - Cash and cash equivalents were $44.8 million as of January 31, 2026, down from $64.8 million as of October 31, 2025 [24] Q&A Session Summary Question: Insights on Calavo acquisition and synergy realization - Management feels confident about the $25 million synergy estimate and sees opportunities for further growth and engagement with customers [32][34] Question: Impact of pricing environment on margins - Management indicated that the majority of costs are variable, and while lower prices compress margins, they aim to maintain profitability through volume [38][40] Question: Timeline for blueberry segment yield improvement - Management expects blueberry farms to reach full productivity in 12-18 months, with improved margins as yields stabilize [44][46] Question: Long-term capital allocation strategy - Management is committed to balancing debt management, reinvestment, and returning capital to shareholders, with a rising priority on shareholder returns [50][52]

Financial Data and Key Metrics Changes - In fiscal year 2026, the company achieved total revenue of $961 million, representing a 24% year-over-year growth, with subscription revenue growing by 26% year-over-year [7][21] - Q4 total revenue was $254 million, growing 21% year-over-year, while subscription revenue reached $192 million, up 23% year-over-year [20][21] - Q4 gross transaction volume (GTV) was $19.8 billion, reflecting a 16% year-over-year growth [20] - Q4 platform gross margin improved to 80%, an increase of 330 basis points year-over-year [22] - Q4 operating income was $27.1 million, resulting in an operating margin of 10.7%, an improvement of 740 basis points year-over-year [23] - Free cash flow for Q4 was $35 million, up from $11 million in the prior year [23] Business Line Data and Key Metrics Changes - Subscription revenue growth was driven by strong performance in Pro, commercial, and new trades [21] - Usage revenue grew 22% year-over-year to $53 million, with fintech utilization remaining strong [21] - Professional services revenue for Q4 was $8.9 million [21] Market Data and Key Metrics Changes - The company exited FY 2026 with approximately 10,800 total active customers, up 14% year-over-year [22] - Net dollar retention was greater than 110% for the quarter, while gross dollar retention was greater than 95% for the full fiscal year [22] Company Strategy and Development Direction - The company aims to continue executing on multi-year growth factors and bring its vision to life with the agentic operating system for the trades [14] - The focus is on leveraging AI to enhance operational velocity and create more value for customers [19][88] - The company plans to expand the Max program, which integrates AI capabilities to automate workflows and improve customer outcomes [12][14] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of AI in removing constraints and enhancing operational efficiency [9][10] - The company expects to maintain a 25% incremental operating margin framework for FY 2027, with a focus on investing in AI and internal tooling [25] - Management expressed confidence in the ongoing strength of free cash flow and the ability to attract world-class talent to capitalize on growth opportunities [29][19] Other Important Information - The company is experiencing strong growth in its partner ecosystem, which contributes to usage revenue [21][64] - The Max program is expected to double the monthly subscription revenue for customers when fully ramped [12][56] Q&A Session Summary Question: Impact of Weather on Q4 Results - Management noted that Q4 was warmer than the previous year, but an ice storm in the last week affected technician availability [28] Question: Incremental Margin Commentary - Management explained that the high incremental margins were driven by overperformance in usage and being behind in hiring, which limited reinvestment opportunities [29] Question: Sales Capacity Investments - Management indicated that while there are opportunities to invest in sales, there is a natural limit to the number of deals that can be pursued in a given year [32] Question: Update on Commercial Business - Management confirmed that the commercial segment is on track and receiving positive customer feedback [35] Question: Scaling the Max Program - Management emphasized the importance of establishing product-market fit before scaling the Max program, focusing on efficient onboarding [38][39] Question: Adoption Curve for Max - Management discussed the potential for Max to deliver significant ROI and the intention to double capacity as adoption increases [45][46] Question: Virtual Agents Contribution - Management clarified that virtual agents are part of the usage consumption and are expected to grow as they handle increased call volumes [62] Question: Partner Monetization - Management explained that partner monetization is a growing part of the business and may lead to usage revenue outpacing GTV growth [64]

Financial Data and Key Metrics Changes - For Q4 2025, diluted earnings per share increased by 23% year-over-year, while for the full year, it grew by 25% year-over-year [7] - Total operating revenue and other income rose by 107% year-over-year to $734 million in Q4, driven by the Mercury acquisition and increased managed receivables [12] - Net income attributable to common shareholders increased approximately 25% year-over-year to $32.8 million in Q4, equating to $1.75 per diluted share [15] Business Line Data and Key Metrics Changes - Managed receivables increased by 37% year-over-year, with new account originations rising by 73% to over 2.2 million for the year [8] - Purchase volume increased by 54% for Q4 year-over-year and by 32% for the full year [8] - The company acquired a $165 million retail credit portfolio from a competitor, enhancing its position in the second look point-of-sale market [7] Market Data and Key Metrics Changes - The company serves approximately 6 million customers, up from 1.2 million five years ago, reflecting a 38% annual growth rate [10] - Return on average equity remained above 20%, even with significant cash reserves of over $600 million at year-end [7] Company Strategy and Development Direction - The acquisition of Mercury Financial effectively doubled the company's balance sheet to approximately $7 billion, enhancing its scale and capabilities [4] - The company aims for long-term earnings growth of 20% or more annually while maintaining returns on average equity of 20% or greater [11] - The integration of Mercury is expected to yield significant long-term earnings accretion through disciplined portfolio management and cost savings [5][6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of consumer behavior, noting consistent payment performance and stable delinquency trends [8] - The competitive landscape remains robust, with record solicitations leading to some softening in response rates and marketing efficiency [9] - Management anticipates a robust tax season, which may lead to a temporary slowdown in growth but will ultimately reduce delinquencies [31] Other Important Information - The company has a diversified funding structure, including partnerships with banks, life insurance companies, and access to the securitization market [25] - Management is considering the potential for applying for bank charters as part of its funding strategy [26] Q&A Session Summary Question: Integration progress of Mercury - Management confirmed that the integration is ahead of schedule, with significant changes in portfolio terms already implemented [19][20] Question: Funding structure and macro concerns - Management stated that funding partners remain supportive, and there has been no deterioration in market conditions for securitization [25] Question: Tax refund season implications - Management expects a robust tax season, which may lead to paydowns affecting balances but ultimately reducing delinquencies [31] Question: Customer concentration management - Management highlighted a diversified merchant base and strong underwriting practices to mitigate concentration risks [35] Question: Fair value mark insights - Management explained that the fair value mark was conservative due to the nature of newly acquired receivables and the Mercury portfolio [47][48]

Financial Data and Key Metrics Changes - In Q4, the company delivered $18.3 million in bookings, near the high end of the guided range, with strong contributions from IP products and TCAD solutions [14] - Revenue reached $18.3 million in the quarter, above the high end of the guided range, with TCAD and IP revenue growing 34% and almost 3x respectively [14][15] - GAAP gross margin in Q4 was 83.3%, and non-GAAP gross margin was 85.6%, reflecting a sequential increase of roughly five full points [15] - GAAP operating loss improved to a $6.8 million loss, while non-GAAP operating loss was just over $1 million, ahead of expectations [17][18] Business Line Data and Key Metrics Changes - TCAD bookings increased 70% sequentially to $9.2 million, driven by the adoption of the AI-driven FTCO solution [6][14] - The semiconductor IP business delivered record revenue and bookings of over $5 million, significantly boosted by the Mixel acquisition [7][14] - EDA bookings and revenue saw a significant decline in Q4, with bookings just under $4 million and revenue of $4.4 million [9][15] Market Data and Key Metrics Changes - The APAC region contributed significantly to growth, accounting for 57% of total revenue in Q4, driven by the FTCO solution [15] - The MIPI PHY market is valued at over $300 million per year, with the company holding a relatively modest share [7] Company Strategy and Development Direction - The company is focused on accelerating its AI-driven solutions, particularly in semiconductor manufacturing process development, which is expected to be a long-term growth driver [5][12] - The restructuring efforts have led to improved gross margins and increased R&D capacity, with a commitment to reducing annualized non-GAAP operating expenses by at least $20 million [17][19] - The company anticipates steady growth in the IP business, with expectations for significant growth in TCAD as contract renewals increase [11][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the turnaround plan, noting that the execution is ahead of expectations and positioning the company for a faster recovery [4][12] - The company expects to approach operating cash flow breakeven in Q2 and achieve positive operating cash flow in Q3 [18][19] - Management highlighted the importance of AI in transforming semiconductor manufacturing processes and improving operational efficiencies [12][24] Other Important Information - The company has seen a significant increase in interest and adoption of its AI solutions, indicating a positive trend for future growth [5][6] - The company is committed to maintaining financial discipline while focusing on key growth opportunities to set the stage for profitable growth [19] Q&A Session Summary Question: Growth priorities and execution - Management highlighted the need for financial flexibility and successful execution of cost reduction programs, leading to improved morale and focus on new opportunities [22][24] Question: Revenue recognition for FTCO deal - A significant portion of the FTCO revenue was recognized in Q4, with the remainder to be recognized over the contract term [28] Question: Bookings expectations by segment - Continued strength in TCAD is expected in Q1, with IP remaining stable and EDA anticipated to be flat sequentially [36] Question: Acceleration of orders from older customers - The pipeline for TCAD growth is expected to be strong in 2026, with a focus on selling the value of new process development paradigms [42] Question: Growth from Mixel acquisition - The company anticipates double-digit revenue growth in the current calendar year, driven by the Mixel acquisition and strong TCAD performance [51][52]